Fate Therapeutics, Inc.

NASDAQ:FATE

Biotechnology

Healthcare
$1.05 -0.00%

-$0.00 today

Market cap
$122.39M
Beta
2.52
P/E (TTM)
-1.8
EPS (TTM)
-$1.08
52W Low $0.91High $2.88

Volume 1.87M

Average 2.92M

Price history

Fate Therapeutics, Inc. SEC filings

Start with how the market priced the stock, then connect its moves to the disclosures filed with the SEC.

Price history

Dividend-adjusted closing price

Period change

+0.00%

Period high

$3.11

Period low

$0.98

Latest

$1.05

SEC filings

What has the company disclosed?

Browse annual, quarterly, and current reports and other filings by form type.

SEC Filings

Recent regulatory filings

FormFiling DateAccepted
424B5Nov 12, 2026Nov 12, 2026
EFFECTNov 12, 2026Nov 13, 2026
SC 13D/ANov 9, 2026Nov 9, 2026
8-KNov 5, 2026Nov 5, 2026
S-3Nov 5, 2026Nov 5, 2026
424B5Nov 5, 2026Nov 5, 2026
8-KNov 5, 2026Nov 5, 2026
10-QNov 5, 2026Nov 5, 2026
4Nov 4, 2026Nov 4, 2026
8-KSep 28, 2026Sep 28, 2026
10-QAug 13, 2026Aug 13, 2026
8-KAug 13, 2026Aug 13, 2026
S-8Aug 13, 2026Aug 13, 2026
4Aug 5, 2026Aug 5, 2026
4Aug 5, 2026Aug 5, 2026

Competitors

Who does Fate Therapeutics, Inc. compete with?

Open similar companies to compare their filings and price history.

Questions

Filing questions

Common questions about FATE's filings, answered from its disclosures.

What is the latest FATE filing?

The latest filing shown is EFFECT dated Nov 12, 2026.

How many recent filings does FATE have?

Intrinsic Alpha currently shows 20 recent filings for FATE.